Additional file 2: of The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis

Tada, Yoshifumi; Ono, Nobuyuki; Suematsu, Rie; Tashiro, Satoko; Sadanaga, Yuri; Tokuda, Yukiko; Ono, Yukihide; Nakao, Yoshinobu; Maruyama, Akihito; Ohta, Akihide; Koarada, Syuichi

doi:10.6084/m9.figshare.c.3645122_D2.v1

12891_2016_1137_MOESM2_ESM.pdf (184.73 kB)

Additional file 2: of The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis

journal contribution

posted on 2016-07-16, 05:00 authored by Yoshifumi Tada, Nobuyuki Ono, Rie Suematsu, Satoko Tashiro, Yuri Sadanaga, Yukiko Tokuda, Yukihide Ono, Yoshinobu Nakao, Akihito Maruyama, Akihide Ohta, Syuichi Koarada

Figure S1. Expression ratios of master regulator genes in rheumatoid arthritis patients before treatment and in control subjects. Figure S2. The correlation between Foxp3/Ror-γt ratio after 24 weeks of Abatacept treatment and delta DAS28CRP (0 and 24 weeks). Figure S3. The correlation between Foxp3/Ror-γt ratio or Ror-γt/GATA3 ratio after 24 weeks of Tocilizumab treatment and delta CDAI (0 and 24 weeks). (PDF 184 kb)